Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc.) on January 8, 2004. The report announces consolidated financial results for the second quarter ended November 30, 2003. The detailed financial data is contained in a press release attached as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibit 99.1 press release, the content of which is not included in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended November 30, 2003.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. It serves solely as a notification that the press release containing this information has been issued.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, as the input metadata incorrectly listed Lifecore Biomedical, Inc.
- Locate and review Exhibit 99.1 (the press release dated January 8, 2004) to obtain actual financial figures for the quarter ended November 30, 2003.
- Confirm the specific revenue and earnings per share numbers in the attached press release to assess performance against prior periods.